We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
Cap. Flow
-$5.59B
Cap. Flow %
-19.76%
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$97.8M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$95.6M
3
LNG icon
Cheniere Energy
LNG
+$94.4M
4
V icon
Visa
V
+$92.5M
5
AZN icon
AstraZeneca
AZN
+$88.2M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Healthcare 17.34%
3 Financials 13.09%
4 Industrials 10.79%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
226
O'Reilly Automotive
ORLY
$75.1B
$33M 0.12%
+783,180
New +$33.7M
RGEN icon
227
Repligen
RGEN
$6.91B
$32.6M 0.12%
200,760
+11,789
+6% +$1.86M
CLH icon
228
Clean Harbors
CLH
$17.2B
$32.4M 0.11%
369,646
+187,591
+103% +$18.1M
THC icon
229
Tenet Healthcare
THC
$22.2B
$32.2M 0.11%
612,675
-230,614
-27% -$16M
FIVN icon
230
FIVE9
FIVN
$2.08B
$32M 0.11%
351,554
+12,447
+4% +$1.26M
CHDN icon
231
Churchill Downs
CHDN
$6.17B
$31.6M 0.11%
329,494
+240,394
+270% +$23.9M
WEX icon
232
WEX
WEX
$6.42B
$31.4M 0.11%
+201,563
New +$33M
TENB icon
233
Tenable Holdings
TENB
$3.47B
$31.2M 0.11%
687,885
+147,032
+27% +$7.58M
CNMD icon
234
CONMED
CNMD
$1.3B
$31.2M 0.11%
325,944
+73,872
+29% +$8.87M
NARI
235
DELISTED
Inari Medical, Inc. Common Stock
NARI
$31.2M 0.11%
458,566
+133,536
+41% +$9.6M
CHH icon
236
Choice Hotels
CHH
$5.26B
$31M 0.11%
277,721
-14,988
-5% -$1.95M
MMI icon
237
Marcus & Millichap
MMI
$1.2B
$30.9M 0.11%
834,672
+92,928
+13% +$4.04M
THRM icon
238
Gentherm
THRM
$1.32B
$30.7M 0.11%
491,315
-10,553
-2% -$710K
GNRC icon
239
Generac Holdings
GNRC
$11.5B
$30.6M 0.11%
145,342
+8,296
+6% +$2.04M
IRTC icon
240
iRhythm Holdings
IRTC
$4.02B
$30.2M 0.11%
279,103
-258,932
-48% -$34.3M
MNST icon
241
Monster Beverage
MNST
$95.1B
$30.1M 0.11%
+650,000
New +$28.3M
MTDR icon
242
Matador Resources
MTDR
$6.04B
$29.9M 0.11%
+641,942
New +$34.9M
MCD icon
243
McDonald's
MCD
$193B
$29.6M 0.1%
120,000
-100
-0.1% -$24.6K
GLOB icon
244
Globant
GLOB
$1.65B
$29.6M 0.1%
170,055
-77,131
-31% -$15.7M
ISRG icon
245
Intuitive Surgical
ISRG
$127B
$29.5M 0.1%
147,107
-273,148
-65% -$64.1M
CLX icon
246
Clorox
CLX
$12B
$29.2M 0.1%
+207,175
New +$29.6M
CEVA icon
247
CEVA Inc
CEVA
$831M
$29.1M 0.1%
867,715
+38,110
+5% +$1.34M
AIG icon
248
American International
AIG
$42.5B
$28.8M 0.1%
563,420
-187,780
-25% -$10.9M
AXON
249
Axon Enterprise
AXON
$42.8B
$28.5M 0.1%
306,406
+10,559
+4% +$1.12M
VAC icon
250
Marriott Vacations Worldwide
VAC
$3.53B
$28.4M 0.1%
244,260
+8,395
+4% +$1.18M

Similar funds

Lord, Abbett & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.

  • Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
  • Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
  • Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
  • Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
  • Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
  • Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
  • Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.